Solid Biosciences (SLDB) Times Interest Earned (2017 - 2026)
Solid Biosciences (SLDB) reported Times Interest Earned of -$10.55 for Q1 2026, up 96.31% on a YoY basis from -$5.38 in Q1 2025, and up 99.89% sequentially from -$9880.6 in Q4 2025.
Solid Biosciences (SLDB) Times Interest Earned (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Times Interest Earned data on file, last reported at -$10.55 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 96.31% year-over-year to -$10.55; the trailing twelve-month figure through Mar 2026 stood at -$36.17 (up 96.46% YoY), and the FY2025 full-year result was -$0.94, up 5.2% from the prior year.
- Times Interest Earned rose to -$10.55 in Q1 2026, from -$9880.6 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.21 in Q4 2022 to a low of -$9880.6 in Q4 2025.
- A 5-year average of -$757.48 and a median of -$218.06 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned plunged 98938.8% in 2025 and surged 96.31% in 2026, its largest moves.
- Tracing SLDB's Times Interest Earned over 5 years: stood at -$0.21 in 2022, then plunged by 2431.42% to -$5.35 in 2023, then sank by 86.49% to -$9.98 in 2024, then tumbled by 98938.8% to -$9880.6 in 2025, then soared by 99.89% to -$10.55 in 2026.
- Business Quant data shows SLDB's Times Interest Earned at -$10.55 in Q1 2026, -$9880.6 in Q4 2025, and -$29.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | -10.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.55 |
| Dec 31, 2025 | -9,880.60 |
| Sep 30, 2025 | -29.00 |
| Jun 30, 2025 | -89.28 |
| Mar 31, 2025 | -286.09 |
| Dec 31, 2024 | -9.98 |
| Sep 30, 2024 | -429.05 |
| Jun 30, 2024 | -315.77 |
| Mar 31, 2024 | -282.76 |
| Dec 31, 2023 | -5.35 |
| Sep 30, 2023 | -218.06 |
| Jun 30, 2023 | -241.83 |
| Mar 31, 2023 | -264.71 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | -108.37 |
| Jun 30, 2022 | -208.05 |
| Mar 31, 2022 | -497.49 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -819.59 |
| Jun 30, 2021 | -1,698.64 |